mewburn-logo-white mewburn-logo
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • en
  • zh-hans
  • germany
  • ja
  • ko
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • All topics
  • Forward
  • Artificial Intelligence
  • Battery Technologies
  • Bioinformatics
  • Brexit
  • Chemistry
  • Commercial Advice
  • Community
  • COVID-19
  • Designs
  • Energy Storage
  • Engineering
  • EU Unitary Patent / Unified Patent Court
  • FemTech
  • Future Food Tech
  • Future Mobility
  • Graphene & 2D Materials
  • Green Tech
  • ICT
  • Life Sciences
  • Litigation
  • Marine & Ocean Engineering
  • Materials
  • MedTech
  • Microbiome
  • Nature based materials
  • Nuclear
  • On-Demand
  • Oppositions
  • Patents
  • Pharmaceuticals
  • Plants
  • Polymers
  • Polymer recycling
  • Precision Medicine
  • Quantum Computing
  • SME
  • Software
  • Space Tech
  • Synthetic Biology
  • Trade Marks
UPC Weekly - Using parallel UPC and EPO proceedings as a strategic tool
Lucy Coe - June 2, 2025

UPC Weekly - Using parallel UPC and EPO proceedings as a strategic tool

2025 Week 22 As we enter the third year of the UPC, we are seeing more and more parallel UPC ...

UPC Weekly - Costs at the UPC – some sharp edges to watch out for
Matthew Naylor - April 28, 2025

UPC Weekly - Costs at the UPC – some sharp edges to watch out for

2025 Week 17 This week we take a look at how the winning party at the UPC should apply for their ...

Killer prior art? Time-limited offer from the UPC to escape costs
Matthew Naylor - March 31, 2025

Killer prior art? Time-limited offer from the UPC to escape costs

2025 Week 13 The UPC will use the big lever of costs awards to direct the behaviour of the parties, ...

UPC Weekly - Some plain speaking from the UPC – on its existence and ambushes
Matthew Naylor - March 24, 2025

UPC Weekly - Some plain speaking from the UPC – on its existence and ambushes

2025 Week 12 There used to be a great rule-of-thumb for reading the headlines of certain British ...

UPC Weekly - UPC Court of Appeal adds more colour to preliminary injunction decisions
Matthew Naylor - March 10, 2025

UPC Weekly - UPC Court of Appeal adds more colour to preliminary injunction decisions

2025 Week 10 We love having a couple of contrasting UPC decisions here at UPC Weekly. This time we ...

UPC Weekly - The wood chipper, the restoration and the avalanche rescue sequel
Matthew Naylor - March 3, 2025

UPC Weekly - The wood chipper, the restoration and the avalanche rescue sequel

2025 Week 9 There are three cases in the mix for discussion this week. First we look at an ...

UPC Weekly - Secrets and files
Matthew Naylor - February 17, 2025

UPC Weekly - Secrets and files

2025 Week 7 One of the richest seams of UPC procedural case law so far is all about how parties can ...

UPC Weekly - Two infringement actions, only one counterclaim for revocation, and an EPO opposition with rocket boosters
Matthew Naylor - February 10, 2025

UPC Weekly - Two infringement actions, only one counterclaim for revocation, and an EPO opposition with rocket boosters

2025 Week 6 Lenovo/Motorola and Ericsson are battling it out in an ongoing global dispute about 5G ...

UPC Weekly - No second bite of the cherry for an intervener at the UPC
Matthew Naylor - January 27, 2025

UPC Weekly - No second bite of the cherry for an intervener at the UPC

2025 Week 4 In the usual run of patent litigation, there is a claimant and a defendant and the rest ...

UPC Weekly - Damages and added matter at the UPC
Matthew Naylor - January 20, 2025

UPC Weekly - Damages and added matter at the UPC

2025 Week 3 The UPC has most definitely kicked into gear. Each week there are increasing numbers of ...

UPC Weekly - UPC transparency by numbers
Matthew Naylor - January 6, 2025

UPC Weekly - UPC transparency by numbers

2025 Week 1 How easy is it to get hold of documents from UPC cases? The easy answer “it depends” is ...

UPC Weekly - Pay to play at the UPC
Matthew Naylor - December 30, 2025

UPC Weekly - Pay to play at the UPC

2024 Week 52 Both Apple and Google have recently succeeded in persuading the UPC Local Division ...

UPC Weekly - UPC gets tough with penalty payment orders
Matthew Naylor - December 23, 2024

UPC Weekly - UPC gets tough with penalty payment orders

2024 Week 51 Great – the UPC has just decided that your patent is valid and infringed. You get an ...

UPC Weekly - Front-loading and obviousness at the UPC
Matthew Naylor - December 2, 2024

UPC Weekly - Front-loading and obviousness at the UPC

2024 Week 48 In NJOY v VMR, the UPC Central Division Paris revoked VMR’s patent EP 3456214 B2 on 27 ...

UPC Weekly - UPC dials up the advantages for patentees
Matthew Naylor - November 18, 2024

UPC Weekly - UPC dials up the advantages for patentees

2024 Week 46 We report this week on two new UPC decisions that make the UPC an even more attractive ...

UPC Weekly - UPC confirms approach to inventive step for life science inventions
Matthew Naylor - October 28, 2024

UPC Weekly - UPC confirms approach to inventive step for life science inventions

2024 Week 43 10x Genomics and NanoString have been duking it out at the UPC since the court opened ...

UPC Weekly - Costs: the UPC’s Big Lever
Matthew Naylor - October 7, 2024

UPC Weekly - Costs: the UPC’s Big Lever

2024 Week 40 This week we report on a UPC Court of Appeal decision that focuses only on costs, and ...

UPC Weekly - The first UPC SEP injunction
Matthew Naylor - September 23, 2024

UPC Weekly - The first UPC SEP injunction

2024 Week 38 On 13 September 2024, the UPC Munich Local Division handed down its decision in the ...

UPC Weekly - Clearing the way can lead to UPC bifurcation and language complexities
Matthew Naylor - September 16, 2024

UPC Weekly - Clearing the way can lead to UPC bifurcation and language complexities

2024 Week 37 Let’s say that you are a company based outside Europe and intend to launch a new ...

UPC Weekly - Revisiting transparency of UPC proceedings
Matthew Naylor - August 19, 2024

UPC Weekly - Revisiting transparency of UPC proceedings

2024 Week 33 The UPC has been doing a lot of stuff right. Litigators praise the preparedness of the ...

UPC Weekly - UPC revocation versus EPO opposition – playing out in not-so-slow-mo
Matthew Naylor - August 5, 2024

UPC Weekly - UPC revocation versus EPO opposition – playing out in not-so-slow-mo

2024 Week 31 What happens when you have the same parties fighting over revocation of the same ...

UPC Weekly - Where’s your UPC off-ramp?
Matthew Naylor - July 29, 2024

UPC Weekly - Where’s your UPC off-ramp?

2024 Week 30 Every litigator needs to have a clear view of the possible routes out of litigation. ...

UPC Weekly - UPC Local Divisions - the reluctant bifurcators
Matthew Naylor - July 15, 2024

UPC Weekly - UPC Local Divisions - the reluctant bifurcators

2024 Week 28 This week we look at how the UPC is handling requests to split substantive ...

UPC Weekly - Opting-out from the UPC: the Who, the When and the Why
Matthew Naylor - June 17, 2024

UPC Weekly - Opting-out from the UPC: the Who, the When and the Why

2024 Week 24 It seems like a long time ago now, but from March to May 2023, the “sunrise period” of ...

UPC Weekly - Should we stay or should we go on?
Matthew Naylor - June 3, 2024

UPC Weekly - Should we stay or should we go on?

2024 Week 22 This week we report on the UPC revocation action in Bitzer v. Carrier and the related ...

UPC Weekly - Let’s talk about costs
Matthew Naylor - May 28, 2024

UPC Weekly - Let’s talk about costs

2024 Week 21 This week we focus how the UPC is dealing with requests for security for costs and the ...

UPC Weekly - High bar to challenge the jurisdiction of the UPC
Matthew Naylor - May 13, 2024

UPC Weekly - High bar to challenge the jurisdiction of the UPC

2024 Week 19 This week saw the UPC issue two decisions about its own jurisdiction. Where a ...

UPC Weekly - Language of proceedings at the UPC
Matthew Naylor - April 22, 2024

UPC Weekly - Language of proceedings at the UPC

2024 Week 16 This week we focus on the language of proceedings at the UPC, considering when the ...

More

  • Slavery Act
  • Legal Notices
  • Terms and Conditions
  • Privacy
  • Forward Community Programme
  • Client Login
  • Join Mewburn Ellis

Follow us

Subscribe

Sign up to Forward: news, insights and features from Mewburn Ellis

Contact

  • mail@mewburn.com
  • London:

    +44 (0)20 7776 5300
  • Bristol:

    +44 (0)117 945 1234
  • Cambridge:

    +44 (0)1223 420383
  • Manchester:

    +44 (0)161 2477 722
  • Munich:

    +49 (0)89 244 459800

Copyright © 2025 Mewburn Ellis. All rights reserved. Terms and Conditions & Online Privacy